B-type Natriuretic Peptide (BNP) Testing

BNP and NT-proBNP testing is covered to help diagnose or exclude heart failure and to assess HF severity in patients presenting with acute dyspnea, and to predict long-term cardiac risk when measured within the first few days after an acute coronary event. Testing is not covered for monitoring or management of chronic/CHF or when used as part of cardiovascular risk assessment panels in asymptomatic patients (screening).

"BNP or NT-proBNP testing is covered to help establish or exclude the diagnosis of heart failure when used in conjunction with other clinical information in patients presenting with acute dyspnea."

Sign up to see full coverage criteria, indications, and limitations.